The Absorption, Metabolism and Excretion of [14C] HQP1351 in Humans

Summary

The objective of this study is to determine the mass balance and routes of excretion of total radioactivity after a single oral 30mg (100µCi) dose of \[14C\] HQP1351 given as a suspension. For further clinical development, human mass balance data are required to elucidate the absorption, metabolism, and excretion of HQP1351.

Timeline

Start

2019-11-19

Primary completion

2020-01-13

Completion

2020-01-13

Drugs

Indications